|  | Cancer | Lymphoma

Lymphogranuloma Venereum (LGV): Stages, Symptoms, Diagnosis & Treatment

LGV: An Invasive Chlamydial Infection

Lymphogranuloma venereum (LGV) is caused by Chlamydia trachomatis serovars L1, L2, L3 (distinct from genital serovars D-K). It invades lymphatic tissue, causing progressive disease if untreated. Rising globally, especially among MSM (men who have sex with men).

Three Clinical Stages

Stage 1: Primary (Inoculation) – 3–30 Days Post-Exposure

  • Small, painless ulcer/papule at entry site (penis, vulva, vagina, cervix, rectum, pharynx).
  • Often unnoticed; heals spontaneously in days.
  • May have inguinal lymphadenopathy (rare at this stage).

Stage 2: Secondary (Invasive) – 2–6 Weeks After Primary Lesion

  • Buboes: Fluctuant, matted inguinal/femoral lymph nodes; may suppurate, form fistulas/sinuses.
  • Groin syndrome: Unilateral (classic) or bilateral; "groove sign" (separation by inguinal ligament).
  • Systemic: Fever, chills, malaise, myalgia, arthralgia.
  • Anorectal syndrome (if rectal exposure): Tenasmus, rectal pain, discharge, bleeding, constipation.
  • Genital ulcers, edema, phimosis (men), vulvar edema (women).

Stage 3: Tertiary (Chronic / Late) – Months to Years

  • Fibrosis, strictures: Rectal/anal stenosis, urethral stricture, vaginal stenosis.
  • Lymphatic obstruction: Elephantiasis of genitals (esthiomene), lymphedema.
  • Chronic fistulas, sinus tracts.
  • Infertility (tubal factor).

Diagnosis

  • NAAT (PCR) for C. trachomatis from lesion swab, bubo aspirate, rectal/pharyngeal swab, urine.
  • LGV-specific PCR (targeting pmpH gene) or genotyping to differentiate from non-LGV chlamydia.
  • Serology (complement fixation, microimmunofluorescence) – supportive, not definitive.
  • Exclude syphilis (RPR/VDRL + confirmatory), HSV, chancroid, donovanosis, TB, Crohn's.

Treatment (CDC/WHO Guidelines)

RegimenDose & DurationNotes
Doxycycline (1st line)100 mg PO BID × 21 daysPreferred; treats buboes & systemic. Contraindicated in pregnancy.
Erythromycin base500 mg PO QID × 21 daysAlternative for pregnancy; GI side effects common.
Azithromycin1 g PO weekly × 3 weeksAlternative; less data for LGV.
  • Bubo aspiration: Needle aspiration (not incision) for fluctuant nodes – repeat as needed. Incision & drainage → chronic sinus.
  • Partner notification & treatment: All contacts last 60 days (or last partner).
  • HIV/STI screening: High co-infection rates (HIV, syphilis, gonorrhea).
  • Follow-up: Clinical resolution of buboes (weeks–months); repeat NAAT at 3–4 weeks if symptomatic.

Prevention

  • Condom use (reduces but doesn't eliminate risk—skin-to-skin transmission).
  • Regular STI screening (q3–6 mo for high-risk).
  • Prompt treatment of genital ulcers.

LGV is curable with prolonged antibiotics. Delayed treatment → irreversible structural damage. High index of suspicion in MSM with proctitis or inguinal buboes.

Lymphoma - Related Articles